Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 122
Filtrar
1.
J Assoc Physicians India ; 72(3): 94-96, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38736126

RESUMO

BACKGROUND: Legionella has a higher prevalence in India than in the world. Legionaries' disease most commonly involves the lungs but because of increased awareness, extrapulmonary manifestations are also being diagnosed more frequently. CASE DESCRIPTION: We present a case of a young female with acute onset of fever and chest pain. On initial investigation, an electrocardiogram (ECG) reported widespread pulse rate (PR) depression suggestive of pericarditis which was confirmed by ECG. High-resolution computed tomography (HRCT) thorax suggested mild bilateral pleural effusion with normal lung parenchyma. elevated erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) added to the diagnosis of serositis. Serological study for atypical organisms was remarkable for positive immunoglobulin M (IgM) for Legionella. She was treated with a high dose of steroids and azithromycin successfully. CONCLUSION: Isolated extrapulmonary presentation of legionaries disease is often overlooked and is common. So it should be always included in the diagnostic armamentarium as treatment is highly efficacious if started early.


Assuntos
Azitromicina , Serosite , Feminino , Humanos , Antibacterianos/uso terapêutico , Azitromicina/uso terapêutico , Eletrocardiografia , Legionella/isolamento & purificação , Legionelose/diagnóstico , Legionelose/tratamento farmacológico , Doença dos Legionários/diagnóstico , Doença dos Legionários/tratamento farmacológico , Serosite/diagnóstico , Serosite/etiologia , Tomografia Computadorizada por Raios X
2.
Clin Lab ; 68(4)2022 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-35443581

RESUMO

BACKGROUND: The goal of the study was to analyze the clinical characteristics of Legionella cases caused by Legionella micdadei and explore the diagnosis and treatment. METHODS: The pathogen was identified by routine isolation and culture, biochemical identification, serum agglutination test, mass spectrometry identification, and routine PCR. Combined with the related literature review, the clinical diagnosis and treatment of Legionella micdadei were analyzed. RESULTS: The patient suffered from pulmonary infection caused by Legionella micdadei. After treatment with moxi-floxacin for 2 weeks, the body temperature dropped and the shadow of the lung was completely absorbed after 2 months. Combined with literature analysis, 8 cases of Legionella micetidis, including 7 males and 1 female, aged from 27 to 57 years old, 6 cases with basic diseases, which were treated with azithromycin, erythromycin or levofloxacin, and all of them achieved good therapeutic effect. CONCLUSIONS: The detection of Legionella should be strengthened in patients with pneumonia whose symptoms have no obvious improvement after antibiotic treatment. Azithromycin, erythromycin or levofloxacin are effective in the treatment of Legionella spp.


Assuntos
Legionella , Legionelose , Pneumonia , Adulto , Azitromicina/farmacologia , Azitromicina/uso terapêutico , Eritromicina/farmacologia , Feminino , Humanos , Legionellaceae , Legionelose/complicações , Legionelose/diagnóstico , Legionelose/tratamento farmacológico , Levofloxacino/farmacologia , Levofloxacino/uso terapêutico , Masculino , Pessoa de Meia-Idade , Pneumonia/diagnóstico
3.
Int J Antimicrob Agents ; 59(1): 106481, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-34801678

RESUMO

OBJECTIVES: Due to recent safety concerns regarding fluoroquinolones and the potential medical and economic benefits, we investigated the efficacy of a single intravenous dose of 1.5 g azithromycin for the treatment of pulmonary legionellosis. METHODS: Using a nationwide legionellosis registry for pre-selection, 74 patients admitted from 2000-2018 to a tertiary care hospital owing to pneumonia caused by Legionella pneumophila were retrospectively included in this study. RESULTS: Conventional treatment regimens consisting of fluoroquinolones (n = 20), macrolides (n = 30) or combinations of both (n = 24) and a single intravenous dose of azithromycin (n = 12) have been demonstrated to be equally effective. Single-dose azithromycin treatment was well tolerated and resulted in a shorter hospital stay (P = 0.0464) and shorter antibiotic treatment duration (P = 0.0004) allowing earlier discharge. CONCLUSION: A single intravenous dose of azithromycin might be a valuable treatment alternative for patients with legionellosis.


Assuntos
Antibacterianos/uso terapêutico , Azitromicina/uso terapêutico , Fluoroquinolonas/uso terapêutico , Legionelose/tratamento farmacológico , Centros de Atenção Terciária/estatística & dados numéricos , Administração Intravenosa , Adulto , Idoso , Áustria , Feminino , Humanos , Legionella pneumophila/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento
4.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 46(10): 1167-1171, 2021 Oct 28.
Artigo em Inglês, Chinês | MEDLINE | ID: mdl-34911849

RESUMO

As a type of Legionella bacteria, Legionella longbeachae bacteria can lead to very rare legionella disease case in China with clinical characteristics, such as no typical early clinical symptoms, strong toxicity, high mortality, and not easy to detect by conventional etiology. A case of severe pneumonia caused by Legionella longbeachae infection was confirmed by bronchoalveolar lavage fluid pathogen metagenomics, and the patient's condition was improved after targeted anti-infection treatment. At present, our understanding in Legionella longbeachae severe pneumonia is limited. The diagnosis and treatment process of the patient with severe pneumonia of Legionella longbeachaeis retrospectively analyzed and the relevant literature was reviewed to provide the experience for its future diagnosis and treatment.


Assuntos
Legionella longbeachae , Legionella , Legionelose , Pneumonia , Humanos , Legionella/genética , Legionella longbeachae/genética , Legionelose/diagnóstico , Legionelose/tratamento farmacológico , Pneumonia/diagnóstico , Estudos Retrospectivos
5.
J Infect Chemother ; 27(5): 751-754, 2021 May.
Artigo em Inglês | MEDLINE | ID: mdl-33402302

RESUMO

Herein, we report the case of a 74-year-old man diagnosed with Legionella pneumonia detected by Loop-Mediated Isothermal Amplification (LAMP) method, which was suspected to have been transmitted from the potting soil. Legionella longbeachae was identified in the sputum culture. The patient was intubated and maintained on mechanical ventilation. Antimicrobial therapy with azithromycin was also administered. His symptoms were resolved and he was discharged after 26 days of hospitalization. Legionella longbeachae pneumonia rarely occurs in Japan, and published literature of Legionella longbeachae pneumonia cases in Japan was reviewed. Patients with severe pneumonia exposed to potting soils, but with negative urinary antigen test results, should be examined by LAMP method.


Assuntos
Legionella longbeachae , Legionella , Legionelose , Pneumonia , Idoso , Humanos , Japão , Legionella/genética , Legionella longbeachae/genética , Legionelose/diagnóstico , Legionelose/tratamento farmacológico , Masculino , Técnicas de Diagnóstico Molecular , Técnicas de Amplificação de Ácido Nucleico , Pneumonia/diagnóstico , Pneumonia/tratamento farmacológico
6.
Emerg Infect Dis ; 26(11): 2725-2727, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-33079050

RESUMO

Legionellosis caused by Legionella longbeachae is diagnosed mainly by PCR. We report a case of L. longbeachae infection in mainland China, which was diagnosed by metagenomic next-generation sequencing, in a man who developed an epileptic seizure after using moxifloxacin. Metagenomic next-generation sequencing may be a useful tool to detect Legionella spp.


Assuntos
Epilepsia/induzido quimicamente , Legionelose , Moxifloxacina/efeitos adversos , Pneumonia Bacteriana/tratamento farmacológico , Convulsões/induzido quimicamente , China , Humanos , Legionella longbeachae , Legionelose/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Moxifloxacina/uso terapêutico
7.
Dermatol Online J ; 26(6)2020 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-32815687

RESUMO

To date, only twenty cases of cutaneous legionellosis have been reported. Cutaneous legionellosis has heterogeneous manifestations including abscesses, nodules, and cellulitis. The detection of most cutaneous Legionella species requires specific diagnostic cultures and assays. Herein, we report a case of cutaneous legionella in a hematopoietic cell transplantation recipient with culture-negative nodules unresponsive to empiric antibiotics. We also discuss the varied morphology of cutaneous legionellosis and important diagnostic considerations.


Assuntos
Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Hospedeiro Imunocomprometido , Legionella , Legionelose/patologia , Dermatopatias Bacterianas/patologia , Adulto , Idoso , Antibacterianos/uso terapêutico , Criança , Diagnóstico Diferencial , Feminino , Humanos , Legionella/isolamento & purificação , Legionelose/diagnóstico , Legionelose/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Dermatopatias Bacterianas/diagnóstico , Dermatopatias Bacterianas/tratamento farmacológico
8.
J Infect Chemother ; 26(5): 411-417, 2020 May.
Artigo em Inglês | MEDLINE | ID: mdl-32081644

RESUMO

Legionella species are consistently identified as some of the most common causative agents of severe community-acquired pneumonia (CAP) or nosocomial pneumonia. Although the number of reported Legionella infection cases is gradually increasing in Japan, most cases are diagnosed by a urinary antigen test, which identifies only L. pneumophila serogroup 1. Therefore, assessment of pneumonia-causing Legionella species and serogroups would be important. The Japan Society for Chemotherapy Legionella committee has collected the isolates and clinical information on cases of sporadic community-acquired Legionella pneumonia throughout Japan. Between December 2006 and March 2019, totally 140 sporadic cases were identified, in which L. pneumophila was the most frequently isolated species (90.7%) followed by L. bozemanae (3.6%), L. dumofii (3.6%), L. micdadei (1.4%), and L. longbeachae (0.7%). Among 127 isolates of L. pneumophila, 111 isolates were of serogroup 1, two of serogroup 2, four of serogroup 3, one of serogroup 4, one of serogroup 5, seven of serogroup 6, and one was of serogroup 10. We also assessed in vitro activity of antibiotics against these isolates and showed that quinolones and macrolides have potent anti-Legionella activity. Our study showed that pneumonia-causing Legionella species and serogroup distribution was comparable to that reported in former surveillances. L. pneumophila was the most common etiologic agent in patients with community-acquired Legionella pneumonia, and L. pneumophila serogroup 1 was the predominant serogroup.


Assuntos
Legionella/classificação , Legionella/isolamento & purificação , Legionelose/microbiologia , Pneumonia Bacteriana/microbiologia , Idoso , Antibacterianos/uso terapêutico , Infecções Comunitárias Adquiridas/tratamento farmacológico , Infecções Comunitárias Adquiridas/microbiologia , Feminino , Humanos , Japão , Legionella pneumophila/classificação , Legionella pneumophila/isolamento & purificação , Legionelose/tratamento farmacológico , Doença dos Legionários/tratamento farmacológico , Doença dos Legionários/microbiologia , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Pneumonia Bacteriana/tratamento farmacológico , Sorogrupo , Sorotipagem
9.
Am J Respir Crit Care Med ; 200(7): e45-e67, 2019 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-31573350

RESUMO

Background: This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia.Methods: A multidisciplinary panel conducted pragmatic systematic reviews of the relevant research and applied Grading of Recommendations, Assessment, Development, and Evaluation methodology for clinical recommendations.Results: The panel addressed 16 specific areas for recommendations spanning questions of diagnostic testing, determination of site of care, selection of initial empiric antibiotic therapy, and subsequent management decisions. Although some recommendations remain unchanged from the 2007 guideline, the availability of results from new therapeutic trials and epidemiological investigations led to revised recommendations for empiric treatment strategies and additional management decisions.Conclusions: The panel formulated and provided the rationale for recommendations on selected diagnostic and treatment strategies for adult patients with community-acquired pneumonia.


Assuntos
Antibacterianos/uso terapêutico , Infecções Comunitárias Adquiridas/diagnóstico , Infecções Comunitárias Adquiridas/tratamento farmacológico , Pneumonia Bacteriana/diagnóstico , Pneumonia Bacteriana/tratamento farmacológico , Adulto , Assistência Ambulatorial , Antígenos de Bactérias/urina , Hemocultura , Infecções por Chlamydophila/diagnóstico , Infecções por Chlamydophila/tratamento farmacológico , Infecções por Chlamydophila/metabolismo , Técnicas de Cultura , Quimioterapia Combinada , Infecções por Haemophilus/diagnóstico , Infecções por Haemophilus/tratamento farmacológico , Infecções por Haemophilus/metabolismo , Hospitalização , Humanos , Legionelose/diagnóstico , Legionelose/tratamento farmacológico , Legionelose/metabolismo , Macrolídeos/uso terapêutico , Infecções por Moraxellaceae/diagnóstico , Infecções por Moraxellaceae/tratamento farmacológico , Infecções por Moraxellaceae/metabolismo , Pneumonia por Mycoplasma/diagnóstico , Pneumonia por Mycoplasma/tratamento farmacológico , Pneumonia por Mycoplasma/metabolismo , Pneumonia Pneumocócica/diagnóstico , Pneumonia Pneumocócica/tratamento farmacológico , Pneumonia Pneumocócica/metabolismo , Pneumonia Estafilocócica/diagnóstico , Pneumonia Estafilocócica/tratamento farmacológico , Pneumonia Estafilocócica/metabolismo , Radiografia Torácica , Índice de Gravidade de Doença , Escarro , Estados Unidos , beta-Lactamas/uso terapêutico
10.
Dtsch Med Wochenschr ; 144(15): 1030-1033, 2019 08.
Artigo em Alemão | MEDLINE | ID: mdl-31350743

RESUMO

Diagnosed and reported Legionella pneumonias are slightly increasing during recent years. This might at least partially be due to more frequently used diagnostic tests.In severe pneumonia, nucleic acid amplification based methods should supplement the L. pneumophila serogroup-1 urinary antigen test because of their improved spectrum and sensitivity.Recent in vitro data suggest enhanced efficacy of levofloxacin when compared to macrolides. This complements recent clinical cohort data. Thus levofloxacin (750-1000 mg/d) is regarded the treatment of choice for confirmed legionellosis. Second line options are azithromycin or moxifloxacin. Treatment duration of 7 days should be sufficient in most cases.Development of resistance is rare and no routine resistance testing is necessary.


Assuntos
Antibacterianos , Legionella/efeitos dos fármacos , Legionelose , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Farmacorresistência Bacteriana , Humanos , Legionelose/diagnóstico , Legionelose/tratamento farmacológico , Legionelose/microbiologia , Levofloxacino/farmacologia , Levofloxacino/uso terapêutico
13.
Neth J Med ; 76(6): 294-297, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30152395

RESUMO

We here report on two immunocompetent patients admitted to our hospital within 3 weeks' time, both suffering from pneumonia caused by Legionella longbeachae (L. longbeachae). The pathogen was identified in broncho-alveolar lavage (BAL) liquid by Polymerase Chain Reaction (PCR), whereas sputum cultures remained negative. This organism is worldwide still relatively unknown and consequently underdiagnosed. However, with an increasing number of confirmed infections in Europe and more specifically in the Netherlands, early awareness and diagnostic measurements are indicated. As routine laboratory techniques like the urine antigen test do not detect L. longbeachae, we advocate early use of specific tests for non-pneumophila Legionella species such as PCR. Furthermore, we advocate the start of empirical antibiotic therapy (i.e. ciprofloxacin) and continuation in suspected cases.


Assuntos
Antibacterianos/uso terapêutico , Legionella longbeachae/isolamento & purificação , Legionelose/diagnóstico por imagem , Legionelose/microbiologia , Reação em Cadeia da Polimerase/métodos , Tomografia Computadorizada por Raios X/métodos , Idoso , Gasometria , DNA Bacteriano/análise , Progressão da Doença , Humanos , Imunocompetência/imunologia , Incidência , Unidades de Terapia Intensiva/estatística & dados numéricos , Legionelose/tratamento farmacológico , Masculino , Países Baixos/epidemiologia , Medição de Risco , Índice de Gravidade de Doença
15.
Rev Med Suisse ; 13(578): 1732-1736, 2017 Oct 11.
Artigo em Francês | MEDLINE | ID: mdl-29022658

RESUMO

Legionellosis refers to the two clinical syndromes caused by Legionella : Pontiac fever, a benign febrile illness and Legionnaires'disease (or pneumonia). Clinically and radiologically, Legionnaires'disease presents itself as a « typical ¼ pneumonia caused by Streptococcus pneumonia. Diagnosis is usually made by using urinary antigen testing. Culture and PCR are also helpful. Legionella is resistant to betalactam antibiotics, and is treated by quinolones or macrolides.


La légionellose regroupe deux entités cliniques : la fièvre de Pontiac, une maladie fébrile bénigne, et la pneumonie à Legionella ou maladie du légionnaire. Sur les plans clinique et radiologique, la pneumonie à Legionella se présente le plus souvent comme une pneumonie « typique ¼ à pneumocoque. Son diagnostic repose généralement sur la mise en évidence d'un antigène de la bactérie dans les urines ; la culture et la PCR sont également des examens utiles. La légionelle est un germe résistant aux bêtalactamines et nécessite un traitement par quinolones ou macrolides.


Assuntos
Legionelose , Doença dos Legionários , Antibacterianos/uso terapêutico , Humanos , Legionelose/diagnóstico , Legionelose/tratamento farmacológico , Doença dos Legionários/diagnóstico , Doença dos Legionários/tratamento farmacológico
17.
Artigo em Japonês | MEDLINE | ID: mdl-28817941

RESUMO

Urinary antigen test is frequently used as a routine laboratory test for early diagnosis of Legionella infection, which is especially suitable for ordinary Legionella pneumophila serogroup 1, but not for other types of Legionella. We report a case of severe pneumonia caused by Legionella longbeachae, where a method of loop-mediated isothermal amplification (LAMP) assay contributed an important role for the early detection. This case involved an 83-year-old man who developed fever, dyspnea, and productive cough. Since the medication of prescribed ceftriaxone had not been effective, he visited the emergency room of our hospital, where an X-ray revealed a severe pneumonia harboring a consolidation with air bronchogram in his right lower lung. His sputum and urine were subjected to the routine bacterial culture or the urinary antigen test for Legionella, which initially brought negative results. However, a positive result of LAMP assay enabled early diagnosis of Legionella pneumonia. Later, the bacterial cultures of sputum made some progress and 16S rRNA sequencing provided a proof of L. longbeachae. This LAMP assay may bring a benefit for the patients with Legionella pneumonia by enabling early detection of not only specific L. pneumophila serogroup 1, but also of the other Legionella species.


Assuntos
Legionella longbeachae/isolamento & purificação , Legionelose/diagnóstico por imagem , Técnicas Microbiológicas , Pneumonia/diagnóstico por imagem , Pneumonia/microbiologia , Idoso de 80 Anos ou mais , Humanos , Legionella longbeachae/genética , Legionelose/tratamento farmacológico , Masculino , Pneumonia/tratamento farmacológico , RNA Ribossômico 23S/isolamento & purificação , Tomografia Computadorizada por Raios X
18.
Int J Hyg Environ Health ; 220(5): 900-905, 2017 07.
Artigo em Inglês | MEDLINE | ID: mdl-28529020

RESUMO

Invasive aspergillosis of the lungs and the central nervous system and Legionella pneumophilia serotype 1 infection of the lungs were diagnosed in a 22-month old child during inpatient induction treatment for T-lymphoblastic leukemia. Environmental investigations i.e. samples from the hospital water system did not reveal any Legionella. The patient may have been exposed to waterborne pathogens despite terminal water filtration due to a technical device to release residual tap water from the hose after showering. A sodium chloride nose spray was found to be contaminated with the A. fumigatus isolate of the patient.


Assuntos
Aspergilose , Infecção Hospitalar , Legionelose , Leucemia-Linfoma Linfoblástico de Células Precursoras , Antibacterianos/uso terapêutico , Antifúngicos/uso terapêutico , Antígenos de Bactérias/análise , Aspergilose/diagnóstico por imagem , Aspergilose/tratamento farmacológico , Aspergilose/microbiologia , Aspergillus fumigatus/imunologia , Aspergillus fumigatus/isolamento & purificação , Encéfalo/diagnóstico por imagem , Líquido da Lavagem Broncoalveolar/microbiologia , Infecção Hospitalar/diagnóstico por imagem , Infecção Hospitalar/tratamento farmacológico , Infecção Hospitalar/microbiologia , Hospitais , Humanos , Lactente , Legionella/isolamento & purificação , Legionelose/diagnóstico por imagem , Legionelose/tratamento farmacológico , Legionelose/microbiologia , Imageamento por Ressonância Magnética , Masculino , Sprays Nasais , Leucemia-Linfoma Linfoblástico de Células Precursoras/diagnóstico por imagem , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/microbiologia , Microbiologia da Água , Poluentes da Água/isolamento & purificação , Abastecimento de Água
19.
Infection ; 45(4): 551-555, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27848164

RESUMO

Legionella spp. are an important cause of pulmonary and rarely extrapulmonary infections. L. cincinnatiensis has only been implicated in five cases to date. We herein report the first case of L. cincinnatiensis septic arthritis in a 90-year old lady with a past medical history of chronic kidney disease. She developed septic arthritis of her left wrist after having received intraarticular corticosteroid injections and oral corticosteroids administered for presumed chondrocalcinosis. Appropriate antimicrobial treatment of L. cincinnatiensis septic arthritis was delayed until identification of this organism in joint biopsies by broad-range bacterial PCR targeting the 16S rRNA gene with subsequent rDNA sequence analysis and by culture on special media. Reviewing all reported cases of septic arthritis caused by Legionella spp. other than L. cincinnatiensis it is notable that diagnosis was established by PCR in the majority of cases and only subsequently confirmed by special culture. Although most patients were immunosuppressed, outcome was favourable. Treatment consisted of a fluoroquinolone alone or in combination with rifampicin or a macrolide. Our case highlights the need for a high index of suspicion for infections with unusual/fastidious organisms when symptoms are suggestive of septic arthritis but conventional methods fail to identify a causative organism.


Assuntos
Anti-Infecciosos/uso terapêutico , Artrite Infecciosa/tratamento farmacológico , Legionella/fisiologia , Legionelose/tratamento farmacológico , Idoso de 80 Anos ou mais , Artrite Infecciosa/microbiologia , Feminino , Fluoroquinolonas/uso terapêutico , Humanos , Hospedeiro Imunocomprometido , Legionella/efeitos dos fármacos , Legionella/genética , Legionelose/diagnóstico , Legionelose/microbiologia , Macrolídeos/uso terapêutico , RNA Bacteriano/análise , RNA Ribossômico 16S/análise , Rifampina/uso terapêutico , Suíça , Resultado do Tratamento
20.
J La State Med Soc ; 168(5): 177-179, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27797349

RESUMO

Legionella pneumophila is a major cause of atypical community-acquired pneumonia, which is commonly severe enough to require hospitalization. Though primarily a respiratory infection, Legionellosis involves the central nervous system (CNS) in up to 50% of patients, and diagnosis can be obscured by the absence of obvious respiratory symptomatology. A reversible diffuse encephalopathy is the most common neurologic complication, but focal CNS involvement can sometimes be the initial presentation. We report a case of a woman infected with Legionella pneumophila presenting with vague symptomatology and focal neurologic findings. This report highlights the challenges of early recognition of Legionella infection when neurologic symptoms predominate.


Assuntos
Confusão/etiologia , Febre/etiologia , Legionelose/diagnóstico , Oftalmoplegia/etiologia , Pneumonia/etiologia , Antibacterianos/uso terapêutico , Diagnóstico Precoce , Feminino , Humanos , Legionelose/tratamento farmacológico , Pessoa de Meia-Idade , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA